Ashok A. Jagasia, MD, PhD, is the director of Rush Oak Park Otolaryngology. Dr. Jagasia graduated with a PhD from Rush University and received his medical degree followed by residency in Otolaryngology – Head and Neck Surgery at Rush University Medical Center. He is board certified by the American Board of Otolaryngology – Head and Neck Surgery. He practices the full scope of comprehensive otolaryngology in adult and pediatric patients and has expertise in the areas of paranasal sinus disease, endoscopic sinus surgery, thyroid, parathyroid, and salivary gland tumors, skin cancers, tonsillectomy, otitis media and sleep apnea. Dr. Jagasia was one of the first to determine the role of the p16 tumor suppressor gene in the development of chondrosarcoma. He pursued a two-year research fellowship in the area of leukemia and lymphoma at Loyola Medical Center and published several articles establishing the role of p16 tumor suppressor gene in the pathogenesis of both solid and hematopoietic malignancies. Dr. Jagasia is currently collaborating with the National Argonne Laboratory on research related to trans-tympanic delivery of topical antibiotics using nanopeptides to treat otitis media. He serves as the Director of the Rush ENT Global Health program, with efforts ranging from surgical trips to Dominican Republic to providing care to rural communities in Illinois. In addition to performing surgeries during the global health trips, he is presently developing a sustainable hearing program for children in the Dominican Republic. Dr. Jagasia has been working with the homeless population in Chicago and established an ENT clinic within the Franciscan Homeless Shelter and is actively engaged in addressing the disparities related to otolaryngology care within the rural communities of Illinois.